| Literature DB >> 35628628 |
Srinivas Akula1,2, Sandra Lara1, Anna-Karin Olsson3, Lars Hellman1.
Abstract
Cell lines of monocyte/macrophage origin are often used as model systems to study monocyte/macrophage biology. A relevant question is how similar these cell lines are to their in vivo counterparts? To address this issue, we performed a detailed analysis of the transcriptome of two commonly used human monocyte/macrophage cell lines, Mono Mac 6 and THP-1. Both of these cell lines originate from leukemic cells with myelo-monocytic characteristics. We found that both Mono Mac 6 and THP-1 represent cells of very immature origin. Their transcriptomes show more similarities to immature neutrophils than cells of the monocyte/macrophage lineage. They express significant levels of N-elastase, proteinase 3, cathepsin G, and azurocidin but very low levels of CD14, ficolin, and complement factor P. All major MHC class II genes are also expressed at low levels. They show high levels of lysozyme and low levels of one of the immunoglobulin Fc receptors, FCGRIIA, which is characteristic of both neutrophils and monocytes. THP-1, but not Mono Mac 6, also expresses the high-affinity receptor for IgG, FCGRIA. Both cell lines lack the expression of the connective tissue components fibronectin, proteoglycan 4, and syndecan 3, which are characteristics of tissue macrophages but are absent in blood monocytes, indicating that they originate from bone marrow precursors and not yolk sac-derived hematopoietic cells. Both of these cell lines seem, therefore, to represent cells arrested during early myelo-monocytic development, at a branch point between neutrophil and monocyte differentiation. Their very immature phenotype indicates that great care should be taken when using these cell lines as models for normal monocyte/macrophage biology.Entities:
Keywords: Mono Mac 6; THP-1; cell line; in vitro; monocyte; neutrophil
Mesh:
Year: 2022 PMID: 35628628 PMCID: PMC9145822 DOI: 10.3390/ijms23105818
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Expression levels for a panel of hematopoietic makers genes in mouse peritoneal macrophages, in two different human monocyte preparations (originating from two different donors) and from two human monocytic cell lines, Mono Mac 6 and THP-1. The number of reads corresponds to the expression level of these genes in the various cell preparations.
| Mouse Peritoneal MQ | H-Monoc. Male Age 51 | H-Monoc. Female Age 61 | Mono Mac 6:1 | Mono Mac 6:2 | THP-1 | |
|---|---|---|---|---|---|---|
|
| ||||||
| CD14 | 627 | 1697 | 1525 | 43 | 53 | 7 |
| CD4 | 0.6 | 594 | 1422 | 0 | 0 | 182 |
| CD40 | 79 | 6 | 19 | 0.3 | 0.6 | 8 |
| CD86 (B7:2) | 257 | 236 | 108 | 9 | 5 | 0.2 |
| MARCO | 28 | 1 | 4 | 0.2 | 0 | 0 |
| CD68 (Binds oxidized LDL) | 638 | 1273 | 547 | 57 | 55 | 486 |
| LYZ (Lysozyme) | 105,000 | 27,394 | 16,400 | 8795 | 8366 | 1087 |
| FCN1 (Ficolin A) | 1306 | 3198 | 2183 | 0 | 0 | 0 |
| CFP (Compl. factor P, Properdin) | 5225 | 991 | 784 | 5 | 4 | 15 |
| ACTB (beta actin) | 7060 | 19,693 | 23,328 | 13,142 | 12,967 | 17,771 |
| FN1 (Fibronectin) | 25,920 | 0 | 0 | 0 | 0 | 0 |
| PRG4 (Proteoglycan 4, Lubricin) | 3606 | 0 | 0 | 0 | 0 | 0 |
| SRGN (Serglycin) | 2803 | 3855 | 5214 | 19,116 | 19,045 | 4522 |
| SDC3 (Syndecan 3) | 3205 | 5 | 7 | 0 | 0 | 20 |
| ECM1 (Extracellular matrix prot.1) | 3180 | 1 | 0.5 | 18 | 15 | 211 |
|
| ||||||
| FCGR2A | - | 580 | 1243 | 66 | 70 | 80 |
| FCGR2B | 9 | 59 | 87 | 0.3 | 0 | 1 |
| FCGR3A (FCGR3) | 1968 | 131 | 297 | 0 | 0 | 0.1 |
| FCGR3B | - | 22 | 6 | 0 | 0 | 0 |
| FCGR1A | 35 | 51 | 60 | 24 | 21 | 203 |
| FCER1A | 0 | 7 | 34 | 0 | 0 | 0.2 |
| FCER2 | 0.3 | 2 | 3 | 0.4 | 0.4 | 0.3 |
| FCER1G | 1318 | 1173 | 2125 | 337 | 318 | 704 |
| FCAR (CD89) | - | 92 | 11 | 0 | 0 | 0.2 |
| FCMR (FAIM3) | 1 | 3 | 4 | 0.4 | 0.5 | 0 |
| FCAMR | 0 | 0 | 0 | 0 | 0 | 80 |
|
| ||||||
| HLA-A | - | 1548 | 1755 | 634 | 750 | 98 |
| HLA-B | - | 6 | 1329 | 570 | 600 | 2 |
| HLA-C | - | 2979 | 1 | 554 | 706 | 4 |
| B2M | 5521 | 4642 | 1801 | 1536 | 2369 | |
| HLA-DRA | - | 5490 | 3645 | 69 | 61 | 16 |
| HLA-DRB1 | - | 3023 | 2188 | 37 | 35 | 303 |
| HLA-DPA1 | - | 2375 | 4099 | 2 | 2 | 7 |
| HLA-DPB1 | - | 1029 | 1506 | 4 | 5 | 3 |
|
| ||||||
| ALOX15 (Arachinodate15 lipoxyg.) | 12,680 | 0 | 0 | 0 | 0 | 0.1 |
| PLA2G7 (Phosplipase A2) | 1549 | 15 | 26 | 0.1 | 0.2 | 3 |
| ALOX5AP (Arach.5-lipoxyg.act prot.) | 1296 | 111 | 85 | 5170 | 5429 | 149 |
| PTGIS (Prosaglandin I syntase) | 1283 | 0 | 0 | 90 | 105 | 0 |
| ALOX5 (Arach. 5 -lipoxygenase) | 494 | 190 | 154 | 2 | 0.6 | 14 |
| DPEP2 (Dipeptidase 2 memb. b.) | 1243 | 77 | 85 | 0.5 | 0.5 | 0.4 |
| APOE (Apolipoprotein E) | 2413 | 2 | 4 | 52 | 65 | 51 |
| PLTP (Phospholipidtransfer protein) | 5788 | 1 | 1 | 76 | 101 | 54 |
|
| ||||||
| CYBB (Cytoch.b-245 (Nox2) Cytb558) | 2664 | 1081 | 867 | 232 | 159 | 19 |
| PADI4 (Peptidyl arg. deim. type IV) | 1029 | 77 | 31 | 0 | 0 | 0 |
| FLNB (Filamin B phagocytosis) | 2235 | 9 | 9 | 103 | 152 | 53 |
| FLNA (Filamin A) | 1458 | 1175 | 494 | 866 | 1023 | 0 |
| TIMD4 (Binds Phosph. Ser. apoptotic cells) | 1244 | 0 | 0 | 0 | 0 | 0.1 |
|
| ||||||
| MPO (Myeolperoxidase) | 0 | 6 | 18 | 15 | 14 | 5 |
| ELANE (Neutrophil Elastase) | 0 | 0.7 | 1 | 1622 | 1817 | 2542 |
| PRTN3 (Proteinase 3) | 68 | 0 | 0 | 68 | 64 | 2635 |
| CTSG (Cathepsin G) | 0.1 | 0.8 | 7725 | 7712 | 1868 | |
| AZU1 (Azurocidin) | - | 3 | 3 | 941 | 894 | 2410 |
| LTF (Lactoferrin) | 0.3 | 0 | 0.1 | 0 | 0 | 0 |
| BPI (Bacterial permeability incr. pr.) | 0 | 62 | 16 | 0 | 0 | 0 |
| DEFB1 (Defensin beta 1) | 0 | 0 | 0.2 | 5 | 4 | 60 |
| Camp (Cathelicidin) | 0 | 1 | 1 | 0 | 0.1 | 2 |
| TPSB2 (Tryptase B2, MCs) | 0 | 0.3 | 179 | 197 | 0.3 | |
| HDC (Histidine decarboxylase) | 42 | 0 | 0.1 | 0 | 0 | 0 |
| MRGPRX2 (MCs) | - | 0 | 0 | 0 | 0 | 0 |
| EPO (EPX) | 0 | 0 | 0 | 0 | 0 | |
| ECP (RNASE3) | 0 | 0.6 | 128 | 123 | 9 | |
| EDN (RNASE2) | 14 | 40 | 786 | 798 | 1076 | |
| MBP (PRG2) | 0.5 | 2 | 0 | 0.6 | 1 | |
|
| ||||||
| TLN1 (Talin 1 cytosk. memb. con.) | 1971 | 248 | 74 | 172 | 159 | 31 |
| ITSN1 (Intersectin 1 membran traf) | 1359 | 0.1 | 0.6 | 0.3 | 0.2 | 1 |
| GRN (Granulin) | 2744 | 588 | 1041 | 1241 | 1443 | 598 |
| BST1 (ADP-ribosyl cyclase 2) | 1204 | 100 | 19 | 7 | 7 | 31 |
| GDA (Guanine deaminase) | 1232 | 0 | 0 | 0 | 0 | 0.1 |
| HAMP (Hepsidin Iron import) | 876 | 0.7 | 0.1 | 0 | 0 | 0 |
| NINJ1 (Ninjurin 1 apoptosis signal?) | 1122 | 578 | 323 | 28 | 25 | 22 |
| HAL (Histidine amonia lyase) | 1561 | 9 | 33 | 66 | 84 | 29 |
| HRG (Histidine-rich glycoprotein) | 0 | 0 | 0 | 0 | 0 | 0 |
Figure 1A schematic representation of the possible developmental arrest in differentiation of the cell lines THP-1 and Mono Mac 6. The tentative position during differentiation of THP-1 and Mono Mac 6 is depicted in the figure, in the context of the myeloid branch of human hematopoiesis, with specific emphasis on the later stages in myelomonocyte differentiation. Marker genes expressed by THP-1, Mono Mac 6, peripheral blood neutrophils, and peripheral blood monocytes are listed to the right of the pictures of the different cells.